Oral Presentation Clinical Oncology Society of Australia Annual Scientific Meeting 2017

The role of the pharmacist in the management of immune-related toxicities (#52)

Christine Carrington 1 , Jim Siderov 2
  1. Department of Pharmacy, Princess Alexandra Hospital, Brisbane, QLD, Australia
  2. Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Heidelberg, VIC, Australia

Pharmacists have an important contribution to make to the clinical team in the management of patients with immune-related adverse effects (IRAE's) particularly where other medication is required to manage the IRAE. The role include

•  A thorough medication history and identification of medication interactions when the patient is taking other medications

•  The assessment of the patient's ability to manage their medications prescribed for IRAE's and ensuring that solutions are implemented to manage any identified barriers to compliance

•  Facilitating continuity of medication management during transition between care settings (e.g. inpatient to outpatient)

•  Patient counselling and provision of education on all medications

This presentation will discuss the evolving role of the pharmacist for this group of patients experiencing IRAE's and how medication management can be optimised.